Evidence map›Paper›PMID 29593730›Full record

ArticleFrontiers in immunology2018

CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3.

Lucía Sanjurjo, Gemma Aran, Érica Téllez, Núria Amézaga, Carolina Armengol, Daniel López, Clara Prats, Maria-Rosa Sarrias

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Baicalin RelievesBiomolecules · 2025
    Article
  14. ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Potential role of liver-resident CD3JHEP reports : innovation in hepatology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lucía SanjurjoInnate Immunity Group, Germans Trias i Pujol Health Sciences Research Institute (IGTP), Barcelona, Spain.
Gemma AranInnate Immunity Group, Germans Trias i Pujol Health Sciences Research Institute (IGTP), Barcelona, Spain.
Érica TéllezInnate Immunity Group, Germans Trias i Pujol Health Sciences Research Institute (IGTP), Barcelona, Spain.
Núria AmézagaInnate Immunity Group, Germans Trias i Pujol Health Sciences Research Institute (IGTP), Barcelona, Spain.
Carolina ArmengolNetwork for Biomedical Research in Hepatic and Digestive Diseases (CIBERehd), Barcelona, Spain.
Daniel LópezDepartament de Física, Escola Superior d'Agricultura de Barcelona, Universitat Politècnica de Catalunya - BarcelonaTech Castelldefels, Barcelona, Spain.
Clara PratsDepartament de Física, Escola Superior d'Agricultura de Barcelona, Universitat Politècnica de Catalunya - BarcelonaTech Castelldefels, Barcelona, Spain.
Maria-Rosa SarriasInnate Immunity Group, Germans Trias i Pujol Health Sciences Research Institute (IGTP), Barcelona, Spain.
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversitat Politècnica de Catalunya · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD5L (CD5 molecule-like) is a secreted glycoprotein that controls key mechanisms in inflammatory responses, with involvement in processes such as infection, atherosclerosis, and cancer. In macrophages, CD5L promotes an anti-inflammatory cytokine profile in response to TLR activation. In the present study, we questioned whether CD5L is able to influence human macrophage plasticity, and drive its polarization toward any specific phenotype. We compared CD5L-induced phenotypic and functional changes to those caused by IFN/LPS, IL4, and IL10 in human monocytes. Phenotypic markers were quantified by RT-qPCR and flow cytometry, and a mathematical algorithm was built for their analysis. Moreover, we compared ROS production, phagocytic capacity, and inflammatory responses to LPS. CD5L drove cells toward a polarization similar to that induced by IL10. Furthermore, IL10- and CD5L-treated macrophages showed increased LC3-II content and colocalization with acidic compartments, thereby pointing to the enhancement of autophagy-dependent processes. Accordingly, siRNA targeting ATG7 in THP1 cells blocked CD5L-induced CD163 and Mer tyrosine kinase mRNA and efferocytosis. In these cells, gene expression profiling and validation indicated the upregulation of the transcription factor ID3 by CD5L through ATG7. In agreement, ID3 silencing reversed polarization by CD5L. Our data point to a significant contribution of CD5L-mediated autophagy to the induction of ID3 and provide the first evidence that CD5L drives macrophage polarization.

Indexed as

Apoptosis Regulatory ProteinsAtherosclerosisAutophagyAutophagy-Related Protein 7Cell DifferentiationCytokinesHumansInflammationInhibitor of Differentiation ProteinsLipopolysaccharidesMacrophagesMonocytesNeoplasm ProteinsPhagocytosisPhenotypeReceptors, ScavengerApoptosis Regulatory ProteinsATG7 protein, humanAutophagy-Related Protein 7CD5L protein, humanCytokinesID3 protein, humanInhibitor of Differentiation ProteinsLipopolysaccharidesNeoplasm ProteinsReceptors, ScavengerRNA, Small InterferingScavenger Receptors, Class BautophagyCD5LefferocytosisID3macrophage polarizationmathematical algorithmphagocytosisscavenger receptor cysteine rich

Identifiers

PMID29593730
PMCPMC5858086
OpenAlexW2794084078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.